Labels on bisphosphonates, a type of medication used to treat and prevent osteoporosis, should further clarify how long patients can take them, an FDA advisory panel voted today.
Source: http://www.webmd.com/osteoporosis/news/20110909/fda-panel-unclear-on-osteoporosis-drug-labels?src=RSS_PUBLIC
Dental Care Depression Detoxification Developmental Disabilities Diabetes Disability
No comments:
Post a Comment